Verition Fund Management
RMD icon

Verition Fund Management’s ResMed RMD Stock Holding History

Verition Fund Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9,600
Closed -$2.37M – 2247
2021
Q2 		$2.37M Buy
+9,600
New +$2.02M 0.02% 469

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Verition Fund Management's RMD Position: Q1 2026 in Review

Verition Fund Management opened a new position in ResMed (RMD) in Q1 2026: 22,394 shares worth $5.03M. The stake represents 0.03% of the portfolio and ranks #578 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in RMD as recently as Q3 2025.

Verition Fund Management first reported a position in RMD in Q2 2013 and has held it in 28 quarters since. The position peaked at $5.94M in Q2 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Verition Fund Management held 22,394 shares of ResMed worth $5.03M as of Q1 2026.
  • ResMed was a new Verition Fund Management position in Q1 2026.
  • ResMed made up 0.03% of Verition Fund Management's portfolio in Q1 2026, its #578 holding.
  • Verition Fund Management first reported a position in ResMed in Q2 2013 and has held it in 28 quarters since.
  • Verition Fund Management's ResMed position peaked at $5.94M in Q2 2025.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.